Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by University of Nebraska.
Recruitment status was  Active, not recruiting
Bristol-Myers Squibb
Information provided by (Responsible Party):
University of Nebraska Identifier:
First received: October 26, 2007
Last updated: December 13, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)